Status:
UNKNOWN
Randomized Clinical Trial for Comparison Of Intravenous Carbeitocin Versus Oxytocin In Management Of Placental Delivery In Second Trimester Interruption
Lead Sponsor:
Wafaa Uthman Ahmed
Collaborating Sponsors:
Ain Shams Maternity Hospital
Conditions:
CARBETOCIN FOR PREVENTION OF PLACENTAL RETAINED
Eligibility:
FEMALE
16-50 years
Phase:
PHASE4
Brief Summary
Intravenous Carbetocin is more efficient than intravenous infusion oxytocin in management of placental delivery in 2nd trimester interruption.
Eligibility Criteria
Inclusion
- Age:16-50 years
- Pregnancy duration: 14-24weeks
- Spontaneous abortion or medical induced abortion at 14-24weeks
Exclusion
- Age less than 16years and more than 50 years
- Surgical termination
- Placenta previa
- Uterine fibroid
Key Trial Info
Start Date :
April 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2013
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT01827124
Start Date
April 1 2013
End Date
December 1 2013
Last Update
October 8 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ain Shams university maternity hospital department of obstetrics and gynacology
Cairo, Tertiary, Egypt